1 Subjects: “...Biological Products / therapeutic use...”

2 Subjects: “...Biological Products / therapeutic use...”

3 “.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...”

4 “.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...”

5 “... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...”

6 “... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...”

7 “...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...”

8 “...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...”

9

10

11 “... to innovator INX, which could lead to patients being switched between products. The purpose of this report...”

12 “... to innovator INX, which could lead to patients being switched between products. The purpose of this report...”

13

14

15

16

17 “... to autoantibody production and abnormal B lymphocyte function. In Canada, the Common Drug Review (CDR) committee...”

18 “... to autoantibody production and abnormal B lymphocyte function. In Canada, the Common Drug Review (CDR) committee...”

19 “... microvascular leakage, and lessen mucus production. Although benefit of its use in CF has not been proven, ICS...”

20 “... microvascular leakage, and lessen mucus production. Although benefit of its use in CF has not been proven, ICS...”